Growth Metrics

Bruker (BRKRP) EPS (Weighted Average and Diluted) (2016 - 2025)

Bruker's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $0.1 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 11.11% year-over-year to $0.1; the TTM value through Dec 2025 reached -$0.15, down 119.74%, while the annual FY2025 figure was -$0.15, 119.74% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.1 in Q4 2025 per BRKRP's latest filing, up from -$0.41 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.4 in Q4 2023 to a low of -$0.41 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.37, with a median of $0.38 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 428.57% in 2021, then tumbled 251.85% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.49 in 2021, then soared by 34.69% to $0.66 in 2022, then skyrocketed by 112.12% to $1.4 in 2023, then plummeted by 93.57% to $0.09 in 2024, then increased by 11.11% to $0.1 in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's EPS (Weighted Average and Diluted) are $0.1 (Q4 2025), -$0.41 (Q3 2025), and $0.05 (Q2 2025).